$CRTO
Criteo S.A. Stock $crto

$crto Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000157642723000073 Filed on May 03, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$468.9M	$445.0M	$510.6M
YoY Change	-5.28%	-12.84%	-5.64%
Cost Of Revenue	$269.2M	$224.4M	$293.7M
YoY Change	-4.07%	-23.58%	-10.38%
Gross Profit	$199.8M	$181.5M	$184.0M
YoY Change	8.0%	-1.37%	2.98%
Gross Profit Margin	42.6%	40.79%	36.04%
Selling, General & Admin	$131.0M	$141.4M	$122.3M
YoY Change	-34.47%	15.59%	8.47%
% of Gross Profit	65.6%	77.91%	66.48%
Research & Development	$67.78M	$63.59M	$34.03M
YoY Change	63.33%	86.88%	7.35%
% of Gross Profit	33.92%	35.03%	18.49%
Depreciation & Amortization	$10.11M	$27.31M	$26.61M
YoY Change	-88.5%	2.63%	54.49%
% of Gross Profit	5.06%	15.05%	14.46%
Operating Expenses	$198.8M	$205.0M	$156.4M
YoY Change	-17.67%	31.11%	8.22%
Operating Profit	$959.0K	-$23.49M	$27.66M
YoY Change	-101.7%	-184.93%	-19.16%
Interest Expense	-$1.927M	$486.0K	$547.0K
YoY Change	-556.64%	-11.15%	1.3%
% of Operating Profit	-200.94%		1.98%
Other Income/Expense, Net	$75.00K	$6.800M	$4.000M
YoY Change	-99.54%	70.0%	-671.43%
Pretax Income	-$893.0K	-$16.67M	$31.69M
YoY Change	-97.77%	-152.59%	-5.4%
Income Tax	$1.078M	-$4.600M	$10.41M
% Of Pretax Income			32.86%
Net Earnings	-$2.876M	-$11.81M	$20.59M
YoY Change	-91.44%	-157.36%	-8.12%
Net Earnings / Revenue	-0.61%	-2.65%	4.03%
Basic Earnings Per Share	-$0.05	-$0.21	$0.34
Diluted Earnings Per Share	-$0.05	-$0.20	$0.32
COMMON SHARES
Basic Shares Outstanding	56.14M shares	55.83M shares	60.74M shares
Diluted Shares Outstanding	55.92M shares	60.49M shares	63.61M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$244.3M	$337.7M	$620.7M
YoY Change	-57.33%	-45.6%	15.45%
Cash & Equivalents	$174.3M	$305.7M	$589.3M
Short-Term Investments	$21.15M	$32.04M	$31.39M
Other Short-Term Assets	$114.4M	$58.12M	$45.46M
YoY Change	191.42%	27.84%	102.1%
Inventory
Prepaid Expenses	$32.69M	$32.42M	$28.35M
Receivables	$573.5M	$545.8M	$479.6M
Other Receivables	$126.5M	$119.4M	$87.27M
Total Short-Term Assets	$1.059B	$1.125B	$1.229B
YoY Change	-11.11%	-8.44%	15.98%
LONG-TERM ASSETS
Property, Plant & Equipment	$244.7M	$146.2M	$129.2M
YoY Change	97.12%	13.2%	-23.13%
Goodwill	$522.5M	$522.8M	$328.1M
YoY Change	61.79%	59.33%	1.64%
Intangibles	$179.2M	$179.9M	$79.44M
YoY Change	129.67%	126.43%	0.0%
Long-Term Investments	$21.61M	$15.42M	$6.855M
YoY Change	340.3%	124.9%	-84.08%
Other Assets	$101.7M	$50.00M	$32.15M
YoY Change	146.19%	55.55%	137.92%
Total Long-Term Assets	$1.070B	$1.066B	$686.5M
YoY Change	57.34%	55.33%	-5.07%
TOTAL ASSETS
Total Short-Term Assets	$1.059B	$1.125B	$1.229B
Total Long-Term Assets	$1.070B	$1.066B	$686.5M
Total Assets	$2.128B	$2.191B	$1.915B
YoY Change	13.77%	14.42%	7.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$624.3M	$602.2M	$378.9M
YoY Change	52.42%	58.95%	8.38%
Accrued Expenses	$132.6M	$132.9M	$125.2M
YoY Change	29.35%	6.16%	7.97%
Deferred Revenue			$1.059M
YoY Change			7.19%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$614.0K	$4.208M	$3.481M
YoY Change	140.78%	20.88%	64.66%
Total Short-Term Liabilities	$949.0M	$992.9M	$612.5M
YoY Change	42.42%	62.1%	9.94%
LONG-TERM LIABILITIES
Long-Term Debt	$75.00K	$76.00K	$354.0K
YoY Change	-77.54%	-78.53%	-4.58%
Other Long-Term Liabilities	$132.7M	$26.29M	$7.676M
YoY Change	2631.57%	242.43%	-21.73%
Total Long-Term Liabilities	$132.8M	$148.4M	$100.3M
YoY Change	40.83%	47.94%	22.71%
TOTAL LIABILITIES
Total Short-Term Liabilities	$949.0M	$992.9M	$612.5M
Total Long-Term Liabilities	$132.8M	$148.4M	$100.3M
Total Liabilities	$1.116B	$1.141B	$712.8M
YoY Change	46.73%	60.11%	11.57%
SHAREHOLDERS EQUITY
Retained Earnings	$527.9M	$551.9M	$619.6M
YoY Change	-8.6%	-10.93%	21.37%
Common Stock	$789.8M	$762.5M	$742.7M
YoY Change	4.89%	2.67%	5.46%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$214.0M	$211.4M	$137.3M
YoY Change	44.13%	53.94%	57.37%
Treasury Stock Shares			5.328M shares
Shareholders Equity	$1.012B	$1.018B	$1.168B
YoY Change
Total Liabilities & Shareholders Equity	$2.128B	$2.191B	$1.915B
YoY Change	13.77%	14.42%	7.44%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$2.876M	-$11.81M	$20.59M
YoY Change	-91.44%	-157.36%	-8.12%
Depreciation, Depletion And Amortization	$10.11M	$27.31M	$26.61M
YoY Change	-88.5%	2.63%	54.49%
Cash From Operating Activities	$1.328M	$41.96M	$74.93M
YoY Change	-90.5%	-44.0%	-3.14%
INVESTING ACTIVITIES
Capital Expenditures	$41.54M	$37.20M	-$10.86M
YoY Change	-289.37%	-442.59%	-21.21%
Acquisitions		$6.500M	$0.00
YoY Change
Other Investing Activities	-$10.69M	$1.093M	$27.78M
YoY Change	-137.77%	-96.07%	-954.31%
Cash From Investing Activities	-$52.24M	-$36.10M	$16.93M
YoY Change	-920.02%	-313.31%	-199.37%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$8.304M
YoY Change			190.76%
Debt Paid & Issued, Net		$0.00	$78.51M
YoY Change		-100.0%	43039.01%
Cash From Financing Activities	-23.90M	-$72.22M	-$1.367M
YoY Change	81.86%	5182.88%	-59.98%
NET CHANGE
Cash From Operating Activities	1.328M	$41.96M	$74.93M
Cash From Investing Activities	-52.24M	-$36.10M	$16.93M
Cash From Financing Activities	-23.90M	-$72.22M	-$1.367M
Net Change In Cash	-74.81M	-$67.54M	$73.82M
YoY Change	-1138.99%	-191.49%	130.32%
FREE CASH FLOW
Cash From Operating Activities	$1.328M	$41.96M	$74.93M
Capital Expenditures	$41.54M	$37.20M	-$10.86M
Free Cash Flow	-$40.22M	$4.769M	$85.79M
YoY Change	-211.99%	-94.44%	-5.88%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001576427
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-36153
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	Criteo S.A.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	I0
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	32 Rue Blanche
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Paris
CY2023Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2023Q1	dei	Entity Address Country EntityAddressCountry	FR
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75009
CY2023Q1	dei	Country Region CountryRegion	33
CY2023Q1	dei	City Area Code CityAreaCode	75
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	85 09 39
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	56136498	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	305662000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	348200000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	50500000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	47800000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	545840000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	708949000	usd
CY2023Q1	crto	Prepaid Income Taxes PrepaidIncomeTaxes	28008000	usd
CY2022Q4	crto	Prepaid Income Taxes PrepaidIncomeTaxes	23609000	usd
CY2023Q1	crto	Prepaid Other Taxes And Other Taxes Receivable PrepaidOtherTaxesAndOtherTaxesReceivable	91354000	usd
CY2022Q4	crto	Prepaid Other Taxes And Other Taxes Receivable PrepaidOtherTaxesAndOtherTaxesReceivable	78274000	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	58116000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	51866000	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	75001000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	25000000	usd
CY2023Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	21168000	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	25098000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	1125149000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	1260996000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	146211000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	131207000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	179877000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	175983000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	522788000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	515140000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	107749000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	102176000	usd
CY2023Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	0	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	75000000	usd
CY2023Q1	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	10875000	usd
CY2022Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	0	usd
CY2023Q1	us-gaap	Nontrade Receivables Noncurrent NontradeReceivablesNoncurrent	4542000	usd
CY2022Q4	us-gaap	Nontrade Receivables Noncurrent NontradeReceivablesNoncurrent	5928000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	50000000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	50818000	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	44296000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	31646000	usd
CY2023Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	1066338000	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1087898000	usd
CY2023Q1	us-gaap	Assets Assets	2191487000	usd
CY2022Q4	us-gaap	Assets Assets	2348894000	usd
CY2023Q1	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	602180000	usd
CY2022Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	742918000	usd
CY2023Q1	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	67149000	usd
CY2022Q4	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	65759000	usd
CY2023Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	16815000	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	13037000	usd
CY2023Q1	crto	Financial Liabilities Current FinancialLiabilitiesCurrent	4208000	usd
CY2022Q4	crto	Financial Liabilities Current FinancialLiabilitiesCurrent	219000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	33287000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	31003000	usd
CY2023Q1	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	60294000	usd
CY2022Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	58031000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	99616000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	85569000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	109367000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	83457000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	992916000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1079993000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	3877000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	3463000	usd
CY2023Q1	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	4138000	usd
CY2022Q4	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	3708000	usd
CY2023Q1	crto	Financial Liabilities Noncurrent FinancialLiabilitiesNoncurrent	76000	usd
CY2022Q4	crto	Financial Liabilities Noncurrent FinancialLiabilitiesNoncurrent	74000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	80762000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	77536000	usd
CY2023Q1	us-gaap	Loss Contingency Accrual Carrying Value Noncurrent LossContingencyAccrualCarryingValueNoncurrent	33244000	usd
CY2022Q4	us-gaap	Loss Contingency Accrual Carrying Value Noncurrent LossContingencyAccrualCarryingValueNoncurrent	33788000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	26285000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	69226000	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	148382000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	187795000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	1141298000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1267788000	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.025
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.025
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	63316696	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	63316696	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	63316696	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	63248728	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	63248728	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	63248728	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	2081000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2079000	usd
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	7323153	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	5985104	shares
CY2023Q1	us-gaap	Treasury Stock Value TreasuryStockValue	211400000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	174293000	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	760397000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	734492000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-85415000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-91890000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	551922000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	577653000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1017585000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1048041000	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	32604000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	33065000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1050189000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1081106000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2191487000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2348894000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	445016000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	510567000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	224398000	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	293650000	usd
CY2023Q1	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	39109000	usd
CY2022Q1	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	32893000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	181509000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	184024000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	63590000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	34027000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	101242000	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	88999000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	40170000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	33336000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	205002000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	156362000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-23493000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	27662000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	6827000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4030000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16666000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	31692000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4595000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10414000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-12071000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	21278000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-11809000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	20587000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-262000	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	691000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56256082	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60738299	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	60494827	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	63613550	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.34
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.20
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.32
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-12071000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	21278000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	6315000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-19218000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	136000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-1086000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	6179000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-18132000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-5892000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	3146000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5334000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4380000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-558000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-1234000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1198320000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	21278000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-18132000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	320000	usd
CY2022Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	8304000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9041000	usd
CY2022Q1	us-gaap	Stockholders Equity Other StockholdersEquityOther	0	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1202523000	usd
CY2022Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	280000000	usd
CY2022Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	303342	shares
CY2022Q1	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	27.4
CY2022Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	183571	shares
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1081106000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-12071000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	6179000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1297000	usd
CY2023Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	51029000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	24707000	usd
CY2023Q1	us-gaap	Stockholders Equity Other StockholdersEquityOther	0	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1050189000	usd
CY2022Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	480000000	usd
CY2022Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	1731634	shares
CY2022Q1	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	29.9
CY2022Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	393585	shares
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-12071000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	21278000	usd
CY2023Q1	us-gaap	Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	31947000	usd
CY2022Q1	us-gaap	Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	34726000	usd
CY2023Q1	crto	Depreciation Depletion And Amortization And Provisions For Various DepreciationDepletionAndAmortizationAndProvisionsForVarious	27311000	usd
CY2022Q1	crto	Depreciation Depletion And Amortization And Provisions For Various DepreciationDepletionAndAmortizationAndProvisionsForVarious	26611000	usd
CY2023Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	8790000	usd
CY2022Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-9000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	25168000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	9489000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-12297000	usd
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2868000	usd
CY2023Q1	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	-137000	usd
CY2022Q1	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	-432000	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-692000	usd
CY2022Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	3819000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	-22088000	usd
CY2022Q1	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	-18926000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-164120000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-92738000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-145011000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-49672000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	13594000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	18947000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	16666000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-3182000	usd
CY2023Q1	crto	Increase Decrease In Operating Lease Liabilities Assets IncreaseDecreaseInOperatingLeaseLiabilitiesAssets	-93000	usd
CY2022Q1	crto	Increase Decrease In Operating Lease Liabilities Assets IncreaseDecreaseInOperatingLeaseLiabilitiesAssets	-2011000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	41964000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	74930000	usd
CY2023Q1	crto	Payments To Acquire Intangible Assets Property Plant And Equipment PaymentsToAcquireIntangibleAssetsPropertyPlantAndEquipment	37195000	usd
CY2022Q1	crto	Payments To Acquire Intangible Assets Property Plant And Equipment PaymentsToAcquireIntangibleAssetsPropertyPlantAndEquipment	10857000	usd
CY2023Q1	crto	Increase Decrease In Accounts Payable Related To Intangible Assets Property Plant And Equipment IncreaseDecreaseInAccountsPayableRelatedToIntangibleAssetsPropertyPlantAndEquipment	3976000	usd
CY2022Q1	crto	Increase Decrease In Accounts Payable Related To Intangible Assets Property Plant And Equipment IncreaseDecreaseInAccountsPayableRelatedToIntangibleAssetsPropertyPlantAndEquipment	5293000	usd
CY2023Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	6500000	usd
CY2022Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2023Q1	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	9625000	usd
CY2022Q1	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	usd
CY2023Q1	crto	Payments For Proceeds From Change In Other Financial Noncurrent Assets PaymentsForProceedsFromChangeInOtherFinancialNoncurrentAssets	6008000	usd
CY2022Q1	crto	Payments For Proceeds From Change In Other Financial Noncurrent Assets PaymentsForProceedsFromChangeInOtherFinancialNoncurrentAssets	-22489000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-36102000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	16925000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	78513000	usd
CY2023Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	usd
CY2022Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	78513000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1266000	usd
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	271000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	51030000	usd
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	8304000	usd
CY2023Q1	crto	Proceeds From Payments For Change In Other Financial Liabilities ProceedsFromPaymentsForChangeInOtherFinancialLiabilities	0	usd
CY2022Q1	crto	Proceeds From Payments For Change In Other Financial Liabilities ProceedsFromPaymentsForChangeInOtherFinancialLiabilities	6666000	usd
CY2023Q1	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	22025000	usd
CY2022Q1	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	usd
CY2023Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-428000	usd
CY2022Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-72217000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1367000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1182000	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-16673000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-67537000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	73815000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	448200000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	515527000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	380663000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	589342000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	7900000	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	7978000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	616000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	365000	usd
CY2023Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	445016000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	510567000	usd
CY2023Q1	crto	Gross Profit And Other Costs Of Revenue GrossProfitAndOtherCostsOfRevenue	220618000	usd
CY2022Q1	crto	Gross Profit And Other Costs Of Revenue GrossProfitAndOtherCostsOfRevenue	216917000	usd
CY2023Q1	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	39109000	usd
CY2022Q1	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	32893000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	181509000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	184024000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	63590000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	34027000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	101242000	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	88999000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	40170000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	33336000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	205002000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	156362000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-23493000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	27662000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	6827000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4030000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16666000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	31692000	usd
CY2023Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2023Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2023Q1	us-gaap	Cash Cash	228055000	usd
CY2023Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	77607000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	305662000	usd
CY2023Q1	us-gaap	Marketable Securities MarketableSecurities	32043000	usd
CY2022Q4	us-gaap	Cash Cash	282293000	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	65907000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	348200000	usd
CY2022Q4	us-gaap	Marketable Securities MarketableSecurities	25098000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale And Held To Maturity Fair Value DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue	32043000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale And Held To Maturity Fair Value DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue	25098000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	100000000	usd
CY2023Q1	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	22000000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	50528000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	47792000	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	75001000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	25000000	usd
CY2023Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	0	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	75000000	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	75001000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	100000000	usd
CY2023Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	596368000	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	756741000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	545840000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	708949000	usd
CY2023Q1	crto	Prepayments To Suppliers PrepaymentsToSuppliers	11910000	usd
CY2022Q4	crto	Prepayments To Suppliers PrepaymentsToSuppliers	12421000	usd
CY2023Q1	crto	Other Debtors OtherDebtors	10806000	usd
CY2022Q4	crto	Other Debtors OtherDebtors	6768000	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	32417000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	24549000	usd
CY2023Q1	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	2983000	usd
CY2022Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	8128000	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	58116000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	51866000	usd
CY2023Q1	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	13196000	usd
CY2022Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	16334000	usd
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent	16871000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	17671000	usd
CY2023Q1	crto	Accounts Payable Capital Expenditures AccountsPayableCapitalExpenditures	28978000	usd
CY2022Q4	crto	Accounts Payable Capital Expenditures AccountsPayableCapitalExpenditures	25414000	usd
CY2023Q1	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	4846000	usd
CY2022Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	2388000	usd
CY2023Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	27000	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	10000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	45449000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	21640000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	109367000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	83457000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	0	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	44696000	usd
CY2023Q1	crto	Uncertain Tax Liability UncertainTaxLiability	18055000	usd
CY2022Q4	crto	Uncertain Tax Liability UncertainTaxLiability	17980000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	8230000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	6550000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	26285000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	69226000	usd
CY2023Q1	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	22000000	usd
CY2023Q1	crto	Uncertain Tax Liability UncertainTaxLiability	18000000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	9280000	usd
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	9616000	usd
CY2023Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	151000	usd
CY2022Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	154000	usd
CY2023Q1	us-gaap	Variable Lease Cost VariableLeaseCost	93000	usd
CY2022Q1	us-gaap	Variable Lease Cost VariableLeaseCost	55000	usd
CY2023Q1	us-gaap	Sublease Income SubleaseIncome	229000	usd
CY2022Q1	us-gaap	Sublease Income SubleaseIncome	172000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	9295000	usd
CY2022Q1	us-gaap	Lease Cost LeaseCost	9653000	usd
CY2023Q1	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	4138000	usd
CY2021Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	5531000	usd
CY2022	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	1756000	usd
CY2022	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	73000	usd
CY2022	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	3311000	usd
CY2022	us-gaap	Defined Benefit Plan Foreign Currency Exchange Rate Changes Benefit Obligation DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation	341000	usd
CY2022Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	3708000	usd
CY2023Q1	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	176000	usd
CY2023Q1	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	41000	usd
CY2023Q1	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	-136000	usd
CY2023Q1	us-gaap	Defined Benefit Plan Foreign Currency Exchange Rate Changes Benefit Obligation DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation	-77000	usd
CY2023Q1	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate	0.0410
CY2022	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate	0.0425
CY2023Q1	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease	0.05
CY2022	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease	0.05
CY2023Q1	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	4078000	usd
CY2022Q1	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	3858000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	23468000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	8274000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	445016000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	510567000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	25168000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9489000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	1700000	usd
CY2022Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	1215000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	23468000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	8274000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	25168000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9489000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	1700000	usd
CY2022Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	1215000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	372329	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	12363	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	400	shares
CY2023Q1	crto	Share Based Compensation Arrangement By Share Based Payment Award Options Cancellations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancellationsInPeriod	0	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	300	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	359266	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	20.65
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y5M26D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue	16.25
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	288866	shares
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	100000	usd
CY2023Q1	crto	Class Of Warrant Or Right Expired During Period ClassOfWarrantOrRightExpiredDuringPeriod	0	shares
CY2023Q1	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P4Y
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	302775	shares
CY2023Q1	crto	Class Of Warrant Or Right Granted During Period ClassOfWarrantOrRightGrantedDuringPeriod	0	shares
CY2023Q1	crto	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod	52223	shares
CY2023Q1	crto	Class Of Warrant Or Right Canceled During Period ClassOfWarrantOrRightCanceledDuringPeriod	0	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	250552	shares
CY2023Q1	crto	Class Of Warrant Or Right Outstanding Weighted Average Grant Date Fair Value ClassOfWarrantOrRightOutstandingWeightedAverageGrantDateFairValue	17.65
CY2023Q1	crto	Class Of Warrant Or Right Vested And Exercisable Weighted Average Remaining Contractual Term ClassOfWarrantOrRightVestedAndExercisableWeightedAverageRemainingContractualTerm	P5Y3M7D
CY2023Q1	crto	Class Of Warrant Or Right Aggregate Intrinsic Value ClassOfWarrantOrRightAggregateIntrinsicValue	19.25
CY2023Q1	crto	Class Of Warrant Or Right Vested And Expected To Vest Exercisable Number ClassOfWarrantOrRightVestedAndExpectedToVestExercisableNumber	230737	shares
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	1063000	usd
CY2022Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	133000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	486000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	547000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1949000	usd
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	4463000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	8199000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-19000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	6827000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4030000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	6800000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4595000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10414000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4600000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10400000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4600000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-11809000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	20587000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56256082	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60738299	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.34
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-11809000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	20587000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56256082	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60738299	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	4062752	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2591530	shares
CY2023Q1	crto	Incremental Common Shares Attributable To Dilutive Effect Of Share Based Payment Arrangements Options And Bspce IncrementalCommonSharesAttributableToDilutiveEffectOfShareBasedPaymentArrangementsOptionsAndBSPCE	118146	shares
CY2022Q1	crto	Incremental Common Shares Attributable To Dilutive Effect Of Share Based Payment Arrangements Options And Bspce IncrementalCommonSharesAttributableToDilutiveEffectOfShareBasedPaymentArrangementsOptionsAndBSPCE	179089	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	57847	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	104632	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	60494827	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	63613550	shares
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.20
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.32
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	497821	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	58840	shares
CY2022Q3	us-gaap	Loss Contingency Estimate Of Possible Loss LossContingencyEstimateOfPossibleLoss	60000000	eur
CY2022Q3	us-gaap	Loss Contingency Estimate Of Possible Loss LossContingencyEstimateOfPossibleLoss	65300000	usd
CY2022Q3	us-gaap	Loss Contingency Estimate Of Possible Loss LossContingencyEstimateOfPossibleLoss	60000000	eur
CY2022Q3	us-gaap	Loss Contingency Estimate Of Possible Loss LossContingencyEstimateOfPossibleLoss	65300000	usd
CY2023Q1	us-gaap	Number Of Countries In Which Entity Operates NumberOfCountriesInWhichEntityOperates	3	market
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	445016000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	510567000	usd
CY2023Q1	us-gaap	Noncurrent Assets NoncurrentAssets	326088000	usd
CY2022Q4	us-gaap	Noncurrent Assets NoncurrentAssets	307190000	usd

Files In Submission

Name	View Source	Status
crto-20230331_pre.xml	Edgar Link	unprocessable
crto-20230331_lab.xml	Edgar Link	unprocessable
0001576427-23-000073-index-headers.html	Edgar Link	pending
0001576427-23-000073-index.html	Edgar Link	pending
0001576427-23-000073.txt	Edgar Link	pending
0001576427-23-000073-xbrl.zip	Edgar Link	pending
crto-20230331.htm	Edgar Link	pending
crto-20230331.xsd	Edgar Link	pending
crto-20230331_cal.xml	Edgar Link	unprocessable
crto-20230331_def.xml	Edgar Link	unprocessable
crto-20230331_htm.xml	Edgar Link	completed
exhibit311ceocertificateq1.htm	Edgar Link	pending
exhibit312cfocertificateq1.htm	Edgar Link	pending
exhibit321ceocfocertificat.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CRTO
Criteo S.A. Stock $crto

2023 Q2 Form 10-Q Financial Statement

#000157642723000073 Filed on May 03, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRTO Criteo S.A. Stock $crto

2023 Q2 Form 10-Q Financial Statement

#000157642723000073 Filed on May 03, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRTO
Criteo S.A. Stock $crto